Dermatology focuses on the health of the skin, hair, and nails. Learn about the diagnosis and treatment of acne, eczema, skin cancer, and cosmetic procedures.
Send us all your questions or requests, and our expert team will assist you.
Diagnosis and evaluation of skin cancer focus on identifying malignant skin changes as early as possible, determining the specific type of cancer, and assessing how deeply the lesion involves the skin or surrounding structures. Because skin cancer can resemble benign skin conditions in its early stages, structured evaluation is essential to distinguish cancerous lesions from noncancerous changes and to guide appropriate management.
Evaluation emphasizes visual assessment, pattern recognition, and tissue examination when needed, rather than reliance on symptoms alone.





Assessment of Lesion Characteristics
During a skin examination, the dermatologist evaluates the size, shape, color, texture, and borders of suspicious lesions. Attention is given to lesions that differ from surrounding skin or that show signs of change over time.
Key features assessed include
• Asymmetry or irregular shape
• Poorly defined or uneven borders
• Variation in color or pigmentation
• Surface changes such as scaling or ulceration
• Growth or thickening over time
The overall pattern of lesions across the body is also considered.
Importance of Lesion History
Skin cancer is often identified by how a lesion changes rather than by how it looks at a single moment. Evaluation includes discussion of whether a spot has grown, changed color, altered texture, or begun to bleed or crust.
A history of ongoing change increases concern even if the lesion is small or minimally symptomatic.
Role of Dermoscopy in Skin Cancer Detection
Dermoscopy is a noninvasive technique that allows detailed visualization of subsurface skin structures. It helps identify patterns associated with melanoma and non-melanoma skin cancers that are not visible to the naked eye.
Dermoscopy supports
• Earlier detection of suspicious lesions
• Better differentiation between benign and malignant findings
• Reduced unnecessary biopsies
It is commonly used during dermatologic evaluation.
When Biopsy Is Recommended
A skin biopsy is performed when a lesion shows features suspicious for skin cancer or when diagnosis cannot be confidently established through examination alone. Biopsy allows microscopic evaluation of skin cells to determine whether cancer is present.
Biopsy is indicated when
• Lesions show progressive change
• Appearance is atypical or concerning
• Symptoms persist without explanation
Biopsy is the definitive diagnostic step.
Pathologic Assessment of Skin Tissue
Histopathologic examination evaluates the cellular structure of the skin sample to identify abnormal growth patterns, cancer type, and depth of involvement. This information confirms whether the lesion is basal cell skin cancer, squamous cell skin cancer, melanoma, or another condition.
Pathology results guide staging and management decisions.
Evaluating Invasion and Spread Risk
Once skin cancer is diagnosed, evaluation focuses on how deeply it extends into the skin and whether there is evidence of spread. Early stage skin cancer is confined to superficial layers, while deeper invasion increases the risk of recurrence or spread.
Staging helps
• Estimate prognosis
Full-Body Skin Examination
Individuals with one skin cancer may be evaluated for additional lesions, especially if they have multiple moles, dysplastic nevi, or a history of prior skin cancers. A full-body skin examination helps identify other suspicious areas that may require monitoring or biopsy.
Distinction From Noncancerous Skin Lesions
Many benign lesions mimic skin cancer, including seborrheic keratoses, benign moles, and inflammatory skin conditions. Diagnostic evaluation focuses on identifying features that distinguish malignant growth from benign findings.
Careful evaluation reduces unnecessary procedures while ensuring concerning lesions are addressed.
Early diagnosis of skin cancer allows simpler treatment and better outcomes. Structured evaluation combining visual examination, dermoscopy, and biopsy when indicated is central to effective dermatologic care.
Liv Hospital Ulus
Asst. Prof. MD. Ayşe Deniz Akkaya
Dermatology
Liv Hospital Ulus
Asst. Prof. MD. Nazlı Caf
Dermatology
Liv Hospital Ulus
Prof. MD. İlteriş Oğuz
Dermatology
Liv Hospital Ulus
Spec. MD. Ömer Gezdur
Dermatology
Liv Hospital Vadistanbul
Assoc. Prof. MD. Ece Altun
Dermatology
Liv Hospital Vadistanbul
Prof. MD. Sevilay Oğuz Kılıç
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Marziyeh Javadpour
Dermatology
Liv Hospital Vadistanbul
Spec. MD. Meryem Ayşit
Dermatology
Liv Hospital Bahçeşehir
Assoc. Prof. MD. Nadir Göksügür
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Esengül Kaya
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Vedat Ertunç
Dermatology
Liv Hospital Bahçeşehir
Spec. MD. Özlem İpek
Dermatology
Liv Hospital Topkapı
Spec. MD. Betül Kızılkan
Dermatology
Liv Hospital Topkapı
Spec. MD. Gizem Gökçedağ Ünsal
Dermatology
Liv Hospital Ankara
Asst. Prof. MD. Caner Demircan
Dermatology
Liv Hospital Ankara
Spec. MD. Aylin Gözübüyükoğulları
Dermatology
Liv Hospital Ankara
Spec. MD. Elçin Akdaş
Dermatology
Liv Hospital Ankara
Spec. MD. Vahid Ahmadi
Dermatology
Liv Hospital Gaziantep
Spec. MD. Hatice Kübra Çakı
Dermatology
Liv Hospital Samsun
Asst. Prof. MD. Gül Şekerlisoy Tatar
Dermatology
Liv Hospital Samsun
Spec. MD. Ayşe İdil Baş
Dermatology
Liv Bona Dea Hospital Bakü
Spec. MD. İRFAN QEHREMANOV
Dermatology
Asst. Prof. MD. A. Deniz Akkaya
Dermatology
MD. Gül Şekerlisoy Tatar
Dermatology
Send us all your questions or requests, and our expert team will assist you.
Through skin examination and confirmed with biopsy when needed.
It improves accuracy but does not replace biopsy.
When a lesion shows suspicious features or ongoing change.
Yes, early detection is common with careful evaluation.
It guides treatment decisions and follow-up planning.
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 67 91